SLN-365

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameSLN-365
Drug Alias NameSLN-365
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionG-protein coupled receptor 146 inhibitors
TargetsG-protein coupled receptor 146
Therapy Area/IndicationsHyperlipoproteinemia Type II
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSilence Therapeutics Plc
China Registration ClassN/A

Develop Information

Active CompaniesSilence Therapeutics Plc
Inactive CompaniesN/A
Active IndicationsHyperlipoproteinemia Type II
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A